98%
921
2 minutes
20
Background: Positron emission tomography (PET) with a [F]fluoroethyl)-L-tyrosine ([F]FET) tracer is of growing importance in the management of glioblastoma for the estimation of tumor extent and extraction of diagnostic and prognostic parameters. Robust and accurate glioblastoma segmentation methods are essential to maximize the benefits of this imaging modality. Given the importance of setting the foreground threshold during manual tumor delineation, this study investigates the added value of incorporating such prior knowledge to guide the automated segmentation and improve performance. Two segmentation networks were trained based on the nnU-Net guidelines: one with the [F]FET PET image as sole input, and one with an additional input channel for the threshold map. For the latter, we investigate the benefit of manually obtained thresholds and explore automated prediction and generation of such maps. A fully automated pipeline was constructed by selecting the best performing threshold prediction approach and cascading this with the tumor segmentation model.
Results: The proposed two-channel network shows increased performance with guidance of threshold maps originating from the same reader whose ground-truth tumor label the prediction is compared to (DSC = 0.901). When threshold maps were generated by a different reader, performance reverted to levels comparable to the one-channel network and inter-reader variability. The proposed full pipeline achieves results on par with current state of the art (DSC = 0.807).
Conclusions: Incorporating a threshold map can significantly improve tumor segmentation performance when it aligns well with the ground-truth label. However, the current inability to reliably reproduce these maps-both manually and automatically-or the ground-truth tumor labels, restricts the achievable accuracy for automated glioblastoma segmentation on [F]FET PET, highlighting the need for more consistent definitions of such ground-truth delineations.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12144010 | PMC |
http://dx.doi.org/10.1186/s40658-025-00767-y | DOI Listing |
Mol Pharmacol
August 2025
Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland. Electronic address:
Although multiparameter cellular morphological profiling methods and three-dimensional (3D) biological model systems can potentially provide complex insights for pharmaceutical discovery campaigns, there have been relatively few reports combining these experimental approaches. In this study, we used the U87 glioblastoma cell line grown in a 3D spheroid format to validate a multiparameter cellular morphological profiling screening method. The steps of this approach include 3D spheroid treatment, cell staining, fully automated digital image acquisition, image segmentation, numerical feature extraction, and multiple machine learning approaches for cellular profiling.
View Article and Find Full Text PDFBMC Med Imaging
September 2025
Department of Radiologic Technology, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Background: Developing quantitative methods to assess post-surgery treatment response in Glioblastoma Multiforme (GBM) is critical for improving patient outcomes and refining current subjective approaches. This study analyzes the performance of machine learning models trained on radiomic datasets derived from magnetic resonance imaging (MRI) scans of GBM patients.
Methods: MRI scans from 143 GBM patients receiving adjuvant therapy post-surgery were acquired and preprocessed.
Clin Radiol
August 2025
Department of Medical Imaging, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China. Electronic address:
Aim: The purpose of this study was to identify the impact of relative contrast enhancement (rCE), based on volumetric segmentation from preconcurrent chemoradiotherapy magnetic resonance imaging (pre-CCRT MRI), in predicting tumour progression and unfavourable survival in glioblastoma (GBM) patients.
Materials And Methods: Seventy-seven GBM patients underwent conventional MRI before and after radiochemotherapy. Residual cavity wall enhancement was segmented using Image J software, and rCE was calculated.
Theranostics
August 2025
Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, 200040, China.
While mass spectrometry (MS) is known for being capable of analyzing a wide range of biomarkers, its usages in clinical settings have been hindered by the stringent requirements for operating the MS analysis system as well as performing the analytical procedure at the point of care (POC). We have developed a miniature MS system and extremely simplified analytical protocols for POC analysis of tumors. It enabled comprehensive metabolite profiling with brain tissue biopsy, which allowed accurate and real-time diagnosis of brain tumors and guiding of surgical resection strategy.
View Article and Find Full Text PDFRadiother Oncol
August 2025
Department of Molecular Imaging and Nuclear Medicine, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin 300060, China. Elect
Purpose: Accurately predicting pseudoprogression (PsP) from tumor progression (TuP) in patients with glioblastoma (GBM) is crucial for treatment and prognosis. This study develops a deep learning (DL) prognostic model using pre- and post-operative contrast-enhanced T1-weighted (CET1) magnetic resonance imaging (MRI) to forecast the likelihood of PsP or TuP following standard GBM treatment.
Method: Brain MRI data and clinical characteristics from 110 GBM patients were divided into a training set (n = 68) and a validation set (n = 42).